HIV/AIDS surveillance and service data analysis in the Republic of Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR)
ArchivedCenters for Disease Control and Prevention
Description
The purpose of this announcement is to provide a funding mechanism in the Republic of Haiti to: • Carry out periodic Antenatal Clinic (ANC) sero-surveys in order to follow the trend of both the HIV/AIDS and syphilis epidemics among pregnant women attending these clinics in the Republic of Haiti. • Perform HIV drug resistance threshold study to evaluate the extent of transmitted HIV drug resistance in sero-sentinel surveillance sites. • Perform periodic triangulation of data in order to demonstrate program impact, identify areas for improvement, direct new programs and enhance existing programs as well as help direct policy changes . • Perform cohort studies to capture data on key aspects of patient care and treatment in a selected number of ART sites of the PEPFAR network at baseline, 6 months, and then yearly in order to assess the performance of the ART sites regarding delivery of treatment.
Who can apply
- Others
Contact
CDC Procurement and Grants Office <br/>Technical Information Management <br/>Phone 770-488-2700
PGOTIM@cdc.gov
- PostedMar 31, 2009
- ClosesMay 29, 2009
- Award floor$300,000
- Award ceiling$300,000
- Program funding$300,000
- Expected awards1
- CFDA93.067
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro